Vical craters on trial failure

"The 390-subject trial failed to demonstrate a statistically significant improvement vs. first-line chemotherapy for either the primary endpoint of objective response rate at 24 weeks or more after randomization or the secondary endpoint of overall survival," Vical said in a press release …

Powered by WPeMatico

This entry was posted in Nigeria News. Bookmark the permalink.

Leave a Reply